Funding · Company
Auron Therapeutics, Inc.
Newton, MABiotech & Pharma
Auron Therapeutics, Inc. of Newton, MA has disclosed $66M across 2 Form D offerings filed with the SEC between Oct 20, 2023 and Dec 23, 2025.
$66M
Total disclosed
2
Form D offerings
2018
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$27M
Form D · Dec 23, 2025 ↗
Q4 2025
· 1 amendment, first filed Dec 31, 2024
· target $42M
$38M
Form D · Oct 20, 2023 ↗
Q4 2023
· 1 amendment, first filed Jul 28, 2022
· target $48M
Filing details
HeadquartersNewton, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2018SEC CIK0001746139Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →